Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 3
2017 1
2018 3
2019 7
2020 10
2021 14
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Cognitive Dysfunctions and Assessments in Multiple Sclerosis.
Oreja-Guevara C, Ayuso Blanco T, Brieva Ruiz L, Hernández Pérez MÁ, Meca-Lallana V, Ramió-Torrentà L. Oreja-Guevara C, et al. Among authors: meca lallana v. Front Neurol. 2019 Jun 4;10:581. doi: 10.3389/fneur.2019.00581. eCollection 2019. Front Neurol. 2019. PMID: 31214113 Free PMC article. Review.
Deciphering Multiple Sclerosis Progression.
Meca-Lallana V, Berenguer-Ruiz L, Carreres-Polo J, Eichau-Madueño S, Ferrer-Lozano J, Forero L, Higueras Y, Téllez Lara N, Vidal-Jordana A, Pérez-Miralles FC. Meca-Lallana V, et al. Front Neurol. 2021 Apr 7;12:608491. doi: 10.3389/fneur.2021.608491. eCollection 2021. Front Neurol. 2021. PMID: 33897583 Free PMC article. Review.
Cognitive impairment in multiple sclerosis: diagnosis and monitoring.
Meca-Lallana V, Gascón-Giménez F, Ginestal-López RC, Higueras Y, Téllez-Lara N, Carreres-Polo J, Eichau-Madueño S, Romero-Imbroda J, Vidal-Jordana Á, Pérez-Miralles F. Meca-Lallana V, et al. Neurol Sci. 2021 Dec;42(12):5183-5193. doi: 10.1007/s10072-021-05165-7. Epub 2021 Apr 1. Neurol Sci. 2021. PMID: 33796947 Free PMC article. Review.
[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
Costa Frossard-França L, García-Domínguez JM, Moreno-Torres I, Fortún J, Villar LM, Meca-Lallana V. Costa Frossard-França L, et al. Among authors: meca lallana v. Rev Neurol. 2021 Apr 1;72(7):250-260. doi: 10.33588/rn.7207.2021097. Rev Neurol. 2021. PMID: 33764494 Free article. Spanish.
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Sabín Muñoz J, Aladro Y, Cárcamo A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez Gines ML, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM. Moreno-Torres I, et al. Among authors: meca lallana v. Eur J Neurol. 2021 Nov;28(11):3712-3721. doi: 10.1111/ene.14990. Epub 2021 Jul 18. Eur J Neurol. 2021. PMID: 34152073 Free PMC article.
Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.
Serra López-Matencio JM, Pérez García Y, Meca-Lallana V, Juárez-Sánchez R, Ursa A, Vega-Piris L, Pascual-Salcedo D, de Vries A, Rispens T, Muñoz-Calleja C. Serra López-Matencio JM, et al. Among authors: meca lallana v. Front Neurol. 2021 Oct 7;12:716548. doi: 10.3389/fneur.2021.716548. eCollection 2021. Front Neurol. 2021. PMID: 34690914 Free PMC article.
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
Meca-Lallana JE, Prefasi D, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Meca-Lallana JE, et al. Among authors: meca lallana v. Patient Prefer Adherence. 2021 Apr 12;15:713-719. doi: 10.2147/PPA.S305707. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33880015 Free PMC article.
COVID-19 will change MS care forever - Yes.
Meca-Lallana V. Meca-Lallana V. Mult Scler. 2020 Sep;26(10):1147-1148. doi: 10.1177/1352458520932767. Epub 2020 Jun 22. Mult Scler. 2020. PMID: 32567486 No abstract available.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: meca lallana v. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940. doi: 10.1212/NXI.0000000000000940. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33408167 Free PMC article.
45 results